Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Novel Formulations For Antimicrobial Peptides

A. M. Carmona-Ribeiro, L. M. Carrasco
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Peptides in general hold much promise as a major ingredient in novel supramolecular assemblies. They may become essential in vaccine design, antimicrobial chemotherapy, cancer immunotherapy, food preservation, organs transplants, design of novel materials for dentistry, formulations against diabetes and other important strategical applications. This review discusses how novel formulations may improve the therapeutic index of antimicrobial peptides by protecting their activity and improving their bioavailability. The diversity of novel formulations using lipids, liposomes, nanoparticles, polymers, micelles, etc., within the limits of nanotechnology may also provide novel applications going beyond antimicrobial chemotherapy.
This paper references
10.1002/cbic.201100671
Solubilized Gramicidin A as Potential Systemic Antibiotics
F. Wang (2012)
10.1099/JMM.0.05286-0
Susceptibility of oral bacteria to an antimicrobial decapeptide.
S. Concannon (2003)
10.1016/J.IDAIRYJ.2007.11.009
Use of nisin and other bacteriocins for preservation of dairy products
A. Sobrino-López (2008)
10.1016/j.ijpharm.2011.01.004
Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers.
C. Di Tommaso (2011)
10.1128/AEM.68.11.5607-5619.2002
Antibacterial Activities of Nisin Z Encapsulated in Liposomes or Produced In Situ by Mixed Culture during Cheddar Cheese Ripening
R. Benech (2002)
10.3109/02652049109021867
Liposomes as carriers of cyclosporin A.
L. Stuhne-Sekalec (1991)
10.1128/AAC.47.8.2538-2544.2003
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
J. Silverman (2003)
10.1002/ADMA.200900189
Design of an Injectable β‐Hairpin Peptide Hydrogel That Kills Methicillin‐Resistant Staphylococcus aureus
Daphne A. Salick (2009)
10.1016/S0006-2952(02)01346-1
Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection.
Abdelwahab Omri (2002)
10.1021/BI9826299
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.
M. Wu (1999)
10.1016/j.jconrel.2010.01.036
Endocytosis of nanomedicines.
G. Sahay (2010)
10.1097/COC.0b013e31815e456d
Antineoplastic Properties of Bacteriocins: Revisiting Potential Active Agents
G. Cornut (2008)
10.1517/17425247.4.4.349
Advanced delivery of Ciclosporin A: present state and perspective
H. Liu (2007)
10.1517/13543784.11.12.1795
Novel therapies for sepsis: antiendotoxin therapies
S. Manocha (2002)
10.1016/j.jcis.2010.06.052
Spontaneous adsorption of silver nanoparticles on Ti/TiO2 surfaces. Antibacterial effect on Pseudomonas aeruginosa.
C. Flores (2010)
10.1016/S0257-8972(03)00703-5
Ultrathin antibacterial polyammonium coatings on polymer surfaces
J. Thome (2003)
[Vancomycin cationic liposome combined with nano-hydroxyapatite/chitosan/konjac glucomannan scaffold for treatment of infected bone defects in rabbits].
Jinliang Huang (2012)
10.1007/s11095-011-0513-7
Self-Assembled Polymersomes Conjugated with Lactoferrin as Novel Drug Carrier for Brain Delivery
Y. Yu (2011)
10.1016/j.bbamem.2014.01.016
High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
G. Wang (2014)
10.1038/ja.2013.81
Structural characterization of thioether-bridged bacteriocins
Christopher T Lohans (2014)
10.1172/JCI6570
Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model.
R. Bals (1999)
10.1016/j.addr.2012.09.015
Nanoparticulate systems for brain delivery of drugs.
J. Kreuter (2001)
10.1016/j.jconrel.2012.04.038
Macromolecular therapeutics in cancer treatment: the EPR effect and beyond.
H. Maeda (2012)
10.1097/00007890-199511150-00021
LIPOSOMAL CYCLOSPORINE: CHARACTERIZATION OF DRUG INCORPORATION AND INTERBILAYER EXCHANGE
C. Ouyang (1995)
10.1186/1472-6831-6-S1-S14
Dental plaque as a biofilm and a microbial community – implications for health and disease
P. Marsh (2006)
10.1189/jlb.0704380
Impact of LL‐37 on anti‐infective immunity
D. Bowdish (2005)
10.1021/ja076300z.s001
Inherent antibacterial activity of a peptide-based beta-hairpin hydrogel.
Daphne A. Salick (2007)
10.1016/j.ijfoodmicro.2012.04.004
Effect of liposome-encapsulated nisin and bacteriocin-like substance P34 on Listeria monocytogenes growth in Minas frescal cheese.
P. S. Malheiros (2012)
10.1021/la101500s
Antimicrobial particles from cationic lipid and polyelectrolytes.
L. D. Melo (2010)
10.1056/NEJMOA053783
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
V. Fowler (2006)
10.1128/AAC.00387-09
Tooth-Binding Micelles for Dental Caries Prevention
F. Chen (2009)
10.1073/pnas.1201559110
Direct visualization of the alamethicin pore formed in a planar phospholipid matrix
Piotr Pieta (2012)
10.1081/DDC-100102155
Rheological characterization of hydroxypropylcellulose gels.
S. Ramachandran (1999)
10.2174/138161207779313795
Controlled delivery of peptides and proteins.
I. T. Değim (2007)
10.1211/0022357022476
The potential of chitosan in ocular drug delivery
M. Alonso (2003)
First in a new class of antibiotics.
(2003)
10.1007/s11095-007-9303-7
Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives
Leena N. Patel (2007)
10.2174/092986706776872925
Lipid bilayer fragments and disks in drug delivery.
A. M. Carmona-Ribeiro (2006)
10.1016/J.DRUDIS.2006.07.015
Disease, destination, dose and delivery aspects of ciclosporin: the state of the art.
J. L. Italia (2006)
10.2147/IJN.S39025
Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method
P. R. Karn (2013)
10.1016/j.peptides.2012.07.005
Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA)
J. Conlon (2012)
10.1016/J.JCONREL.2004.10.010
Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.
H. Yamamoto (2005)
10.1002/jbm.a.34166
Targeted delivery of vancomycin to Staphylococcus epidermidis biofilms using a fibrinogen-derived peptide.
Christopher M. Hofmann (2012)
10.1128/AEM.68.8.3683-3690.2002
Inhibition of Listeria innocua in Cheddar Cheese by Addition of Nisin Z in Liposomes or by In Situ Production in Mixed Culture
R. Benech (2002)
10.1016/j.ijantimicag.2010.10.011
Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA).
A. Pumerantz (2011)
10.1371/journal.pone.0005724
Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis
M. Alipour (2009)
10.1016/S0939-6411(00)00143-0
Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers.
R. Gref (2001)
10.3390/ph7050545
Human Antimicrobial Peptides and Proteins
G. Wang (2014)
10.1038/nmat2915
A polycationic antimicrobial and biocompatible hydrogel with microbe membrane suctioning ability.
Peng Li (2011)
Efficacy of endotoxin adsorption therapy (polymyxin B hemoperfusion) for methicillin-resistant Staphylococcus aureus toxic shock syndrome: a case report about five patients.
T. Taniguchi (2013)
10.1128/JB.185.16.4693-4698.2003
Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity.
J. Kaplan (2003)
10.1167/iovs.11-8829
A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.
C. Di Tommaso (2012)
10.1074/JBC.M310251200
Structure-activity determinants in paneth cell alpha-defensins: loss-of-function in mouse cryptdin-4 by charge-reversal at arginine residue positions.
H. Tanabe (2004)
10.2174/156720109789941722
Preparation and characterization of superporous hydrogels as pH-sensitive drug delivery system for Pantoprazole sodium.
Gupta Nv (2009)
10.2217/17435889.3.1.1
From fluorescence nanoscopy to nanoscopic medicine.
R. Peters (2008)
10.2147/IJN.S19259
Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt
Peipei Guan (2011)
10.1016/j.biomaterials.2012.08.046
Arginine-rich self-assembling peptides as potent antibacterial gels.
A. Veiga (2012)
10.1517/13543784.12.2.117
Novel agents for the treatment of resistant Gram-positive infections
N. Woodford (2003)
Polymyxin-B hemoperfusion for acute exacerbation of idiopathic pulmonary fibrosis: serum IL-7 as a prognostic marker.
K. Tachibana (2011)
10.1086/504084
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus.
J. Patel (2006)
10.2174/138920109787048661
Structure-function relationships of the non-lanthionine-containing peptide (class II) bacteriocins produced by gram-positive bacteria.
J. Nissen-Meyer (2009)
10.1128/AAC.01254-08
Immobilization Reduces the Activity of Surface-Bound Cationic Antimicrobial Peptides with No Influence upon the Activity Spectrum
M. Bagheri (2008)
10.1016/j.ijpharm.2008.12.007
Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
R. Yang (2009)
10.1016/J.FOODCONT.2011.09.025
Production of nisin-loaded solid lipid nanoparticles for sustained antimicrobial activity
P. Prombutara (2012)
10.2147/IJN.S9035
Biomimetic nanoparticles: preparation, characterization and biomedical applications
A. M. Carmona-Ribeiro (2010)
From controlled release to pH-responsive drug delivery
P Gupta (2002)
J. Bacteriol
(2003)
10.1016/S0005-2736(99)00198-4
Diversity of antimicrobial peptides and their mechanisms of action.
R. Epand (1999)
10.1016/j.ijpharm.2010.01.038
Novel milk-based oral formulations: proof of concept.
G. Charkoftaki (2010)
10.1021/LA063718M
Highly effective contact antimicrobial surfaces via polymer surface modifiers.
P. Kurt (2007)
10.1155/2014/837215
Food Antimicrobials Nanocarriers
Adriana Blanco-Padilla (2014)
10.1016/j.ejpb.2012.02.014
Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
C. Di Tommaso (2012)
10.1016/S0378-5173(98)00066-0
Oral administration of liposomes containing cyclosporine: a pharmacokinetic study
M. Al-Meshal (1998)
10.1016/0378-5173(94)00243-X
Characterization, stability and in vivo targeting of liposomal formulations containing cyclosporin
A. Al-Angary (1995)
10.1016/S0021-9673(00)00343-5
Analysis of polymyxin B sulfate by capillary zone electrophoresis with cyclodextrin as additive. Method development and validation.
J. Kang (2000)
10.1016/j.survophthal.2009.02.002
Topical ophthalmic cyclosporine: pharmacology and clinical uses.
E. Donnenfeld (2009)
Food antimicrobials nanocarriers. Sci. World J
A Blanco-Padilla (2014)
10.1128/AEM.02150-07
Capacity of Human Nisin- and Pediocin-Producing Lactic Acid Bacteria To Reduce Intestinal Colonization by Vancomycin-Resistant Enterococci
M. Millette (2008)
10.1155/2012/604204
Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb
F. Lallemand (2012)
10.2147/IJN.S39685
Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles
L. Zhang (2013)
10.1111/j.1524-475X.2007.00321.x
Biofilms in chronic wounds
G. James (2008)
10.1084/JEM.192.7.1069
Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells
De Yang (2000)
10.1016/S0378-5173(00)00680-3
Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral.
J. Guo (2001)
10.1023/A:1016054306763
Preparation and Characterization of Freeze-dried Chitosan-Poly(Ethylene Oxide) Hydrogels for Site-Specific Antibiotic Delivery in the Stomach
V. Patel (2004)
10.1021/ar200256e
Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
I. Nakase (2012)
10.1271/BBB1924.24.44
Modified Starch. I
K. Horitsu (1960)
10.1128/CMR.00043-12
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
L. Fernández (2012)
J. Am. Chem. Soc
(2011)
J. Biomater. Sci. Polym. Ed
(2011)
10.1046/j.1526-0968.2003.00005.x
Extracorporeal Endotoxin Removal For The Treatment of Sepsis:Endotoxin Adsorption Cartridge (Toraymyxin)
H. Shoji (2003)
10.1016/0006-8993(95)01375-X
Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections
U. Schroeder (1996)
10.1371/journal.pone.0097261
The Self-Assembly of a Cyclic Lipopeptides Mixture Secreted by a B. megaterium Strain and Its Implications on Activity against a Sensitive Bacillus Species
M. Pueyo (2014)
10.3389/fmicb.2013.00321
Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides
K. C. Mulder (2013)
10.1016/j.jcis.2010.02.032
Effect of α-helical peptides on liposome structure: a comparative study of melittin and alamethicin.
P. Wessman (2010)
10.1001/jama.2009.856
Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
D. Cruz (2009)
10.1016/j.actbio.2008.10.001
Peptide-directed self-assembly of hydrogels.
J. Kopeček (2009)
10.1177/0895937409335627
Antimicrobial Peptides for Plaque Control
K. Leung (2009)
10.1016/j.addr.2012.11.005
Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
L. Mei (2013)
10.1016/j.addr.2009.06.001
Recent advances in the use of cell-penetrating peptides for medical and biological applications.
S. Fonseca (2009)
10.1016/J.BIOMATERIALS.2007.06.012
Permanent, non-leaching antibacterial surface--2: how high density cationic surfaces kill bacterial cells.
Hironobu Murata (2007)
10.1016/S0939-6411(03)00138-3
Cyclosporine A delivery to the eye: a pharmaceutical challenge.
F. Lallemand (2003)
10.1111/j.1574-6968.2011.02223.x
The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against gram-negative bacteria in combination with EDTA treatment.
Leah A Martin-Visscher (2011)
10.1021/LA970353K
Cationic Vesicles as Bactericides
L. Martins (1997)
10.1016/j.ijpharm.2010.07.001
Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin.
Abdallah Makhlof (2010)
10.1128/MMBR.70.1.121-146.2006
Chemoenzymatic and Template-Directed Synthesis of Bioactive Macrocyclic Peptides
Jan Grünewald (2006)
10.1016/J.BCP.2006.01.012
Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro.
S. Maher (2006)
10.2147/IJN.S48197
Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes
C. Lee (2013)
10.1097/01.shk.0000159930.87737.8a
A PILOT-CONTROLLED STUDY OF A POLYMYXIN B-IMMOBILIZED HEMOPERFUSION CARTRIDGE IN PATIENTS WITH SEVERE SEPSIS SECONDARY TO INTRA-ABDOMINAL INFECTION
J. Vincent (2005)
10.3389/fmicb.2014.00097
Defensins: antifungal lessons from eukaryotes
P. Silva (2014)
10.1002/JPS.1115
In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide.
C. F. Lange (2001)
10.2174/138161212799277617
Therapeutic potential of host defense peptides in antibiotic-resistant infections.
Nicole J Afacan (2012)
10.1146/ANNUREV.BIOCHEM.76.010307.145803
Lipid A modification systems in gram-negative bacteria.
C. Raetz (2007)
10.1038/srep01557
Imaging the action of antimicrobial peptides on living bacterial cells
M. Gee (2013)
10.1042/BJ3150345
Peptide models for membrane channels.
D. Marsh (1996)
10.3390/ijms14059906
Cationic Antimicrobial Polymers and Their Assemblies
A. M. Carmona-Ribeiro (2013)
10.1016/0005-2736(88)90069-7
Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects.
H. Steiner (1988)
10.2147/IJN.S4937
Nanomedicine in pulmonary delivery
H. M. Mansour (2009)
10.1111/j.1067-1927.2004.012303.x
HB‐107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair
Phillip H. A. Lee (2004)
10.1016/j.bbamem.2008.05.009
Melittin-lipid interaction: a comparative study using liposomes, micelles and bilayer disks.
A. Lundquist (2008)
10.1371/journal.pone.0076844
Value Addition in the Efficacy of Conventional Antibiotics by Nisin against Salmonella
A. Singh (2013)
10.1021/JA076300Z
Inherent Antibacterial Activity of a Peptide-Based β-Hairpin Hydrogel
Daphne A. Salick (2007)
10.1016/J.BBAMEM.2006.04.006
Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action.
D. I. Chan (2006)
10.3109/1061186X.2013.847098
Brain delivery of proteins via their fatty acid and block copolymer modifications
X. Yi (2013)
10.1016/J.BPC.2004.09.006
Development and initial evaluation of PEG-stabilized bilayer disks as novel model membranes.
E. Johansson (2005)
10.1021/jp064757
Gram-negative outer and inner membrane models: insertion of cyclic cationic lipopeptides.
A. Clausell (2007)
10.1016/S1359-6446(02)02255-9
Hydrogels: from controlled release to pH-responsive drug delivery.
P. Gupta (2002)
10.1016/J.JCONREL.2005.07.024
Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
Celeste A. Roney (2005)
10.3109/10611869808997871
Drug delivery systems for cyclosporine: achievements and complications.
B. A. Klyashchitsky (1998)
10.1146/annurev-pharmtox-010611-134535
Emerging themes and therapeutic prospects for anti-infective peptides.
N. Yount (2012)
10.1128/CMR.17.2.323-347.2004
Invasion of the Central Nervous System by Intracellular Bacteria
D. Drevets (2004)
10.1007/s00018-011-0711-9
Lipid complexes with cationic peptides and OAKs; their role in antimicrobial action and in the delivery of antimicrobial agents
R. F. Epand (2011)
10.1021/bi400773q
Simulating the mechanism of antimicrobial lipopeptides with all-atom molecular dynamics.
Joshua N. Horn (2013)
10.3390/ijms15045852
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
M. Paranjpe (2014)
10.3928/01477447-20120327-42
Daptomycin resistance in prosthetic joint infections.
B. Sivakumar (2012)
10.1016/J.EURURO.2005.12.043
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines.
J. Lehmann (2006)
10.2174/157489112803521904
PEGylated liposomal vancomycin: a glimmer of hope for improving treatment outcomes in MRSA pneumonia.
A. Pumerantz (2012)
10.1002/mabi.201000316
Dipeptide and tripeptide conjugates as low-molecular-weight hydrogelators.
D. Adams (2011)
10.3390/10010065
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs
F. Delié (2005)
10.4155/tde.14.13
Liposomal antibiotic formulations for targeting the lungs in the treatment of Pseudomonas aeruginosa.
M. Alipour (2014)
10.1016/j.addr.2009.03.009
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
10.1016/j.biomaterials.2012.06.091
Silk sericin/polyacrylamide in situ forming hydrogels for dermal reconstruction.
Banani Kundu (2012)
10.1016/S0958-6946(02)00194-2
Liposome encapsulated nisin Z: optimization, stability and release during milk fermentation
R. Laridi (2003)
The amphipathic helix in cytotoxic peptides
I. Cornut (1993)
10.1016/S0169-409X(97)00125-7
Protein release from gelatin matrices.
Ikada (1998)
10.3109/1040841X.2012.749210
Revisiting eukaryotic anti-infective biotherapeutics
P. Rishi (2014)
10.1016/J.MICRON.2007.06.013
Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting.
Jean-Christophe Colas (2007)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons
10.4065/80.9.1215
Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia.
J. K. Long (2005)
10.1016/j.jconrel.2011.08.029
PEG-stabilized lipid disks as carriers for amphiphilic antimicrobial peptides.
M. Zetterberg (2011)
10.1007/s11095-006-9104-4
A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics
G. Dumortier (2006)
10.1086/420818
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.
R. Arbeit (2004)
10.1186/cc5780
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
D. Cruz (2007)
10.1016/S0378-5173(99)00260-4
Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles.
M. Lee (1999)
10.2174/138161206779026254
Colloidal microgels in drug delivery applications.
S. Vinogradov (2006)
Poly (vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug
J. K. Li (1998)
10.1007/s00423-008-0395-2
Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation
T. Shimizu (2008)
10.1097/CCM.0b013e31828cf412
Blood Purification and Mortality in Sepsis: A Meta-Analysis of Randomized Trials*
F. Zhou (2013)
10.3390/molecules19068610
Catalytic Behavior of Lipase Immobilized onto Congo Red and PEG-Decorated Particles
R. A. Silva (2014)
10.1002/btpr.640
Assembly of horseradish peroxidase within supported cationic bilayers
Ana Carolina Leão-Silva (2011)
10.1016/J.NANTOD.2009.08.008
Self-assembled and nanostructured hydrogels for drug delivery and tissue engineering
H. J. Chung (2009)
10.1016/j.ijpharm.2013.07.002
Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation.
C. Luschmann (2013)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1021/JM00076A002
Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations.
N. El Tayar (1993)
10.1053/JHIN.2002.1332
Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus.
T. Nakamura (2003)
10.1016/B978-1-4831-6753-4.50010-7
The physical chemistry of gelatin.
A. Veis (1965)
10.1099/MIC.0.27757-0
Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry.
V. Miao (2005)
10.1073/PNAS.88.9.3792
Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation.
R. Cruciani (1991)
10.1016/j.drudis.2013.12.002
Immunosuppressive peptides and their therapeutic applications☆
Kathrin Thell (2014)
10.1371/journal.pone.0076172
Exendin-4 Protects Mitochondria from Reactive Oxygen Species Induced Apoptosis in Pancreatic Beta Cells
Z. Li (2013)
10.1128/CMR.00056-05
Peptide Antimicrobial Agents
H. Jenssen (2006)
10.1128/CMR.00030-13
A Current Perspective on Daptomycin for the Clinical Microbiologist
R. Humphries (2013)
10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D
Animal antimicrobial peptides: an overview.
D. Andreu (1998)
10.1007/s00248-008-9464-x
Lipopeptides Produced by a Soil Bacillus Megaterium Strain
M. Pueyo (2008)
10.1007/s11095-010-0119-5
Triclosan-Loaded Tooth-Binding Micelles for Prevention and Treatment of Dental Biofilm
F. Chen (2010)
10.1038/sj.gt.3301938
Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium
M. Lee (2003)
10.1016/j.fm.2010.05.001
Characterisation of an antiviral pediocin-like bacteriocin produced by Enterococcus faecium.
S. Todorov (2010)
10.1128/MMBR.00016-05
The Continuing Story of Class IIa Bacteriocins
D. Drider (2006)
10.1016/j.coph.2009.08.002
New approaches in peptide antibiotics.
M. Vaara (2009)
10.1007/s00249-004-0402-7
Effect of micellar charge on the conformation and dynamics of melittin
H. Raghuraman (2004)
10.1007/s11095-013-1105-5
The Development of Dentotropic Micelles with Biodegradable Tooth-Binding Moieties
F. Chen (2013)
Fungicidal nanoparticles of low toxicity from cationic lipid and polyelectrolytes
A. M. Carmona-Ribeiro (2012)
10.1007/s00284-014-0519-6
Antibiofilm and Antimicrobial Efficacy of DispersinB®-KSL-W Peptide-Based Wound Gel Against Chronic Wound Infection Associated Bacteria
P. V. Gawande (2014)
10.1002/JBM.B.30960
Characterization of the physicochemical, antimicrobial, and drug release properties of thermoresponsive hydrogel copolymers designed for medical device applications.
D. Jones (2008)
10.1126/SCIENCE.286.5439.525
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.
D. Yang (1999)
10.1038/nnano.2009.153
Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent.
L. Liu (2009)
10.1016/j.cell.2006.02.015
Pathogen Recognition and Innate Immunity
S. Akira (2006)
10.1021/JP003315+
Interactions between Cationic Vesicles and Candida albicans
M. T. Campanhã (2001)
10.1021/J100039A047
Effect of bilayer phase transitions on vesicle structure and its influence on the kinetics of viologen reduction.
M. Andersson (1995)
10.1038/nrmicro1273
Food microbiology: Bacteriocins: developing innate immunity for food
P. Cotter (2005)
10.1038/333276A0
Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings
N. Schnell (1988)
10.1038/35106587
Innate antimicrobial peptide protects the skin from invasive bacterial infection
V. Nizet (2001)
10.1002/9783527626878.CH14
Method Development and Validation
J. Fritz (2009)
10.1016/S0021-9673(01)00585-4
Isolation and structural characterization of polymyxin B components.
J. Orwa (2001)
10.1016/j.biomaterials.2009.12.042
The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis.
Hua-Ying Wang (2010)
10.1016/J.EJPB.2004.03.033
The potential of lipid emulsion for ocular delivery of lipophilic drugs.
S. Tamilvanan (2004)
10.1128/AAC.42.10.2534
Identification and Characterization of Novel Antimicrobial Decapeptides Generated by Combinatorial Chemistry
S. Y. Hong (1998)
10.1128/AAC.39.2.301
Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.
S. Haynie (1995)
10.1093/JAC/38.5.865
Penetration of vancomycin into human lung tissue.
M. Cruciani (1996)
10.1016/S0939-6411(00)00090-4
Hydrogels in pharmaceutical formulations.
N. Peppas (2000)
Antitumor activity of magainin analogues against human lung cancer cell lines.
Y. Ohsaki (1992)
Design of an injectable beta-hairpin peptide hydrogel that kills methicillin-resistant Staphylococcus aureus
D. A. Salick (2009)
CHEWING GUM AS A DRUG DELIVERY SYSTEM
Y. Patel (2011)
10.1021/LA980345J
Interactions between cationic vesicles and serum proteins
L. Carvalho (1998)
10.1128/AAC.00143-14
Efficacy of the Novel Topical Antimicrobial Agent PXL150 in a Mouse Model of Surgical Site Infections
J. Håkansson (2014)
10.1016/j.biomaterials.2011.02.013
The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides.
Guangzheng Gao (2011)
10.1021/ja200079a
Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization.
N. Schmidt (2011)
10.1371/journal.pone.0016400
Highly Selective End-Tagged Antimicrobial Peptides Derived from PRELP
M. Malmsten (2011)
10.2147/IJN.S42617
Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium
Yufan Ma (2013)
10.1016/j.ijpharm.2007.11.035
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
M. Alipour (2008)
10.4161/viru.1.5.12983
Antimicrobial peptides: The ancient arm of the human immune system
J. Wiesner (2010)
10.1007/BF01715542
Enhanced killing of methicillin-resistantStaphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin
C. Onyeji (1994)
Isolation and structural characterization of polymyxin
J. A. Orwa (2001)
10.1128/AAC.50.3.1079-1082.2006
Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
L. Cui (2006)
Listeria--review of epidemiology and pathogenesis.
Vidhya Ramaswamy (2007)
10.1056/NEJM199102143240701
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
E. Ziegler (1991)
10.1016/J.IJPHARM.2007.05.035
Cyclodextrin/PEG based hydrogels for multi-drug delivery.
S. Salmaso (2007)
10.2174/138920109787048616
Lantibiotics: mode of action, biosynthesis and bioengineering.
G. Bierbaum (2009)
10.1201/9781420015164
Food Polysaccharides and Their Applications
A. M. Stephen (2006)
10.1155/2013/507539
Immunomodulation in Sepsis: The Role of Endotoxin Removal by Polymyxin B-Immobilized Cartridge
E. Esteban (2013)
Preparation and characterization of superporous hydrogels as pH-sensitive drug delivery system for Pantoprazole sodium.
N. V. Gupta (2009)
10.1016/j.jconrel.2010.11.024
Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide.
L. Bi (2011)
10.1038/nrmicro2761
The rise of the Enterococcus: beyond vancomycin resistance
C. Arias (2012)
10.1016/J.TIFS.2010.03.003
Food applications of liposome-encapsulated antimicrobial peptides.
P. S. Malheiros (2010)
10.1111/j.1368-5031.2005.00885.x
Daptomycin: first in a new class of antibiotics for complicated skin and soft‐tissue infections
W. Kern (2006)
10.1021/BI971009P
Quantitative studies on the melittin-induced leakage mechanism of lipid vesicles.
S. Rex (1998)
10.1002/pbc.22447
Polymyxin‐direct hemoperfusion for sepsis‐induced multiple organ failure
K. Hirabayashi (2010)
10.3168/JDS.S0022-0302(03)73776-X
Impact of nisin producing culture and liposome-encapsulated nisin on ripening of Lactobacillus added-Cheddar cheese.
R. Benech (2003)
10.1186/1741-7007-2-4
Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin
J. M. Harms (2004)
10.1021/LA061884O
Immobilized horseradish peroxidase as a reusable catalyst for emulsion polymerization.
A. F. Naves (2007)
10.1179/joc.2004.16.2.119
In-Vitro Activity of Nisin Against Clinical Isolates of Clostridium difficile
A. Bartoloni (2004)
10.1016/S1473-3099(10)70220-6
Endotoxin removal devices for the treatment of sepsis and septic shock.
B. Davies (2011)
10.1016/j.peptides.2014.04.019
Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents
J. Conlon (2014)
10.1038/nchembio.1393
Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.
A. Hilchie (2013)
10.1038/nrmicro2745
Modulating immunity as a therapy for bacterial infections
R. Hancock (2012)
10.1093/JAC/39.SUPPL_1.7
Inhibition of protein synthesis by streptogramins and related antibiotics.
C. Cocito (1997)
10.1016/0300-9572(95)94129-W
Treatment of septic shock with human monoclonal antibody HA-1A: A randomized, double-blind, placebo-controlled trial
R. V. McCloskey (1995)
Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery
S. Futaki (2001)
Biofilms in chronic wounds. Wound Repair Regen
G A James (2008)
10.1016/s0021-9258(17)42737-2
The action of virginiamycin M on the acceptor, donor, and catalytic sites of peptidyltransferase.
G. Chinali (1984)
10.1159/000088016
Changes in Plasma Interleukin-18 by Direct Hemoperfusion with Polymyxin B-Immobilized Fiber in Patients with Septic Shock
T. Nakamura (2005)
10.1016/B978-012513910-6/50061-X
Chapter 4 – INTERACTIONS BETWEEN BILAYER VESICLES, BIOMOLECULES, AND INTERFACES
A. M. Carmona-Ribeiro (2001)
Nanocarriers for antibiotics. In Nanotechnology for Animal Health and Production
G Yordanov
10.1163/092050611X570644
Nano-Hydroxyapatite/Chitosan/Konjac Glucomannan Scaffolds Loaded with Cationic Liposomal Vancomycin: Preparation, In Vitro Release and Activity against Staphylococcus aureus Biofilms
T. Ma (2011)
10.2478/s11658-008-0041-6
Oral cyclosporine A - the current picture of its liposomal and other delivery systems
A. Czogalla (2008)
10.1155/2012/896141
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
L. Tang (2012)
10.1126/SCIENCE.7690158
High-resolution conformation of gramicidin A in a lipid bilayer by solid-state NMR.
R. Ketchem (1993)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1111/j.1582-4934.2008.00341.x
Development of a novel antimicrobial peptide, AG-30, with angiogenic properties
T. Nishikawa (2009)
VANCOMYCIN CATIONIC LIPOSOME COMBINED WITH NANO-HYDROXYAPATITE/CHITOSAN/KONJAC GLUCOMANNAN SCAFFOLD FOR TREATMENT OF INFECTED BONE DEFECTS IN RABBITS
徐永清 (2012)
10.3389/fmicb.2014.00001
Molecular characterization of vulnibactin biosynthesis in Vibrio vulnificus indicates the existence of an alternative siderophore
Wenzhi Tan (2014)
10.2217/fmb.13.39
Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
T. Velkov (2013)
10.1039/c2nr32006a
Unzipping the role of chirality in nanoscale self-assembly of tripeptide hydrogels.
S. Marchesan (2012)
10.1517/14712598.4.6.881
Hydrogels for oral delivery of therapeutic proteins
N. Peppas (2004)
10.1039/c2cc16609g
Tripeptide self-assembled hydrogels: unexpected twists of chirality.
S. Marchesan (2012)
10.1002/ADFM.201002138
Guest‐Molecule‐Directed Assembly of Mesostructured Nanocomposite Polymer/Organoclay Hydrogels
J. Martin (2011)
10.2147/IJN.S1045
Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases
Malgorzata Smola (2008)
10.1039/B402722A
NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin.
L. Ball (2004)
10.1177/039139880602900210
Multi-Scale Analysis of the Toraymyxin Adsorption Cartridge Part I: Molecular Interaction of Polymyxin B with Endotoxins
S. Vesentini (2006)
10.2174/138945012802002302
Nanotools for the delivery of antimicrobial peptides.
Patricia Urban (2012)
10.3390/molecules181114122
Polymeric Systems of Antimicrobial Peptides—Strategies and Potential Applications
M. Sobczak (2013)
10.1016/J.IJFOODMICRO.2007.06.001
Bacteriocin-based strategies for food biopreservation.
A. Gálvez (2007)
Interactions between cationic liposomes and bacteria: the physical-chemistry of the bactericidal action.
M. T. Campanhã (1999)
10.1128/AAC.01530-12
The Two-Component System CprRS Senses Cationic Peptides and Triggers Adaptive Resistance in Pseudomonas aeruginosa Independently of ParRS
L. Fernández (2012)
10.1093/JAC/DKM357
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
A. Zavascki (2007)
10.1006/JSRE.2001.6340
Local pharmaceutical release from a new hydrogel implant.
P. Petratos (2002)
10.1016/0005-2736(79)90046-4
Physicochemical studies of the protein-lipid interactions in melittin-containing micelles.
J. Lauterwein (1979)
Interactions between bilayer vesicles, biomolecules, and interfaces. In Handbook of Surfaces and Interfaces of Materials; Nalwa, H.S., Ed.; Academic Press: Burlington
A. M. Carmona-Ribeiro (2001)
10.1074/jbc.M611003200
Toward Understanding the Cationicity of Defensins
G. Zou (2007)
Eisenstein, B.I. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
R D Arbeit (2004)
10.1021/jf904378e
In vitro digestibility and emulsification properties of phytoglycogen octenyl succinate.
Siqi L Scheffler (2010)
10.1016/S0005-2736(99)00206-0
Simulation studies of the interaction of antimicrobial peptides and lipid bilayers.
P. L. La Rocca (1999)
10.1016/J.LWT.2011.07.017
Release and antilisterial properties of nisin from zein capsules spray-dried at different temperatures
D. Xiao (2011)
10.13172/2052-0069-2-3-983
Fungicidal assemblies and their mode of action
A. M. Carmona-Ribeiro (2013)
10.1093/jac/dkp221
A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.
Clare Piper (2009)
10.1529/BIOPHYSJ.105.074245
1H and 13C-NMR and molecular dynamics studies of cyclosporin a interacting with magnesium(II) or cerium(III) in acetonitrile. Conformational changes and cis-trans conversion of peptide bonds.
F. Bernardi (2006)
10.1080/03639040601155665
Cyclosporine A: A Review of Current Oral and Intravenous Delivery Systems
Pascal R Beauchesne (2007)
10.1021/am200150t
Structure-activity relationship for quaternary ammonium compounds hybridized with poly(methyl methacrylate).
L. D. Melo (2011)
10.1016/j.febslet.2009.06.051
Selective arginines are important for the antibacterial activity and host cell interaction of human α‐defensin 5
Erik P. H. de Leeuw (2009)
SPECIALIZED ORAL MUCOSAL DRUG DELIVERY SYSTEMS : CHEWING GUM
M. Rassing (1996)
10.1590/S1517-838220120004000024
Inhibition of Listeria monocytogenes in minas frescal cheese by free and nanovesicle-encapsulated nisin
P. S. Malheiros (2012)
Treatment of septic shock with human monoclonal antibodyHA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group
R V Mccloskey (1994)
10.1016/j.ejphar.2009.08.043
Cationic amphiphilic peptides with cancer-selective toxicity.
F. Schweizer (2009)
10.1111/J.1600-051X.1987.TB00994.X
Prevention of plaque growth with chewing gum containing chlorhexidine acetate.
J. Ainamo (1987)
10.2217/fmb.11.27
Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development.
R. Eckert (2011)
10.1016/S0168-3659(98)00089-3
Poly(vinyl alcohol) nanoparticles prepared by freezing-thawing process for protein/peptide drug delivery.
J. K. Li (1998)
10.1182/BLOOD.V97.1.297
Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds.
A. M. Cole (2001)
10.1073/pnas.1308268110
High-resolution crystal structure reveals molecular details of target recognition by bacitracin
N. J. Economou (2013)
10.5301/IJAO.2009.2704
Therapeutic potential of biofilm-dispersing enzymes.
J. Kaplan (2009)
10.1006/FMIC.1997.0160
Comparative antimicrobial activity of enterocin L50, pediocin PA-1, nisin A and lactocin S against spoilage and foodborne pathogenic bacteria.
L. Cintas (1998)
1H- and 13C-NMR and molecular dynamics studies of cyclosporin a interacting with magnesium (II) or cerium (III) in acetonitrile. Conformational changes and cis-trans conversion of peptide
F. Bernardi (2006)
10.1371/journal.pone.0058530
Saturation Mutagenesis of Lysine 12 Leads to the Identification of Derivatives of Nisin A with Enhanced Antimicrobial Activity
Evelyn M. Molloy (2013)
10.1016/S0378-5173(02)00337-X
Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms.
S. Futaki (2002)
10.1016/J.JCONREL.2007.10.027
Delivery systems to increase the selectivity of antibiotics in phagocytic cells.
E. Briones (2008)
10.2174/1389557511209030202
Daptomycin: a review of properties, clinical use, drug delivery and resistance.
C. Vilhena (2012)
10.1016/j.mib.2013.06.013
Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies.
César de la Fuente-Núñez (2013)
10.1155/2011/591325
Liposome Technology for Industrial Purposes
A. Wagner (2011)
10.1016/S0272-6386(00)70348-9
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future.
A. D. de Mattos (2000)
10.7326/0003-4819-121-1-199407010-00001
Treatment of Septic Shock with Human Monoclonal Antibody HA-1A
R. V. McCloskey (1994)
10.1016/j.bbamem.2012.08.008
Interaction of gramicidin with DPPC/DODAB bilayer fragments.
C. A. Carvalho (2012)
10.1371/journal.pone.0043958
Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content
N. Mishra (2012)
10.1016/J.JCONREL.2005.05.027
Chewing gum of antimicrobial decapeptide (KSL) as a sustained antiplaque agent: preformulation study.
D. Na (2005)
10.1016/S0140-6736(97)80051-7
Peptide antibiotics
Robert EW Hancock (1956)
10.1016/S1473-3099(10)70143-2
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
K. Kumarasamy (2010)
10.3109/09273948.2010.498657
Clinical Review: Topical Ophthalmic Use of Cyclosporin A
C. Utine (2010)
Protein release from gelatin
Y. Ikada (1998)
10.1529/BIOPHYSJ.104.047456
Effects of phenylalanine substitutions in gramicidin A on the kinetics of channel formation in vesicles and channel structure in SDS micelles.
J. B. Jordan (2005)
10.2147/IJN.S40904
Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery
X. Wu (2013)
10.1053/AJKD.2002.32767
Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
K. Uriu (2002)
10.1128/AAC.40.11.2523
Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics.
J. Allignet (1996)
10.1016/S0378-5173(01)00614-7
Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats.
Q. Zhang (2001)
10.1023/A:1022664406840
In Vitro Evaluation of Nebulization Properties, Antimicrobial Activity, and Regional Airway Surface Liquid Concentration of Liposomal Polymyxin B Sulfate
T. Desai (2004)
10.1097/ICO.0b013e31825e83f4
Distribution of Cyclosporine A in Ocular Tissues After Topical Administration of Cyclosporine A Cationic Emulsions to Pigmented Rabbits
Philippe Daull (2013)
10.1016/j.colsurfb.2013.03.024
Enzymatic activity of cholesterol oxidase immobilized onto polymer nanoparticles mediated by Congo red.
R. A. Silva (2013)
10.3389/fmicb.2014.00116
Antifungal defensins and their role in plant defense
A. F. Lacerda (2014)
10.1016/J.FOODCONT.2013.09.024
Surfactant assisted nisin loaded chitosan-carageenan nanocapsule synthesis for controlling food pathogens
Meenu Chopra (2014)
10.5772/57543
Cationic Nanostructures for Vaccines
A. M. Carmona-Ribeiro (2014)
Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery
(2001)
10.1016/j.ijantimicag.2010.01.015
Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria.
D. Nicolosi (2010)
10.1016/j.ejpb.2010.09.012
Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study.
K. Mondon (2011)
10.1021/J100166A080
Bilayer structure and stability in dihexadecyl phosphate dispersions
A. M. Carmona-Ribeiro (1991)
10.1016/j.biomaterials.2013.01.096
Self-assembly of ciprofloxacin and a tripeptide into an antimicrobial nanostructured hydrogel.
S. Marchesan (2013)
10.1111/j.1742-481X.2011.00923.x
A critical review of modern and emerging absorbent dressings used to treat exuding wounds
I. Sweeney (2012)
10.1007/s11095-007-9274-8
Stability of Antimicrobial Decapeptide (KSL) and Its Analogues for Delivery in the Oral Cavity
Dong Hee Na (2007)
10.1021/jf903170b
Phytoglycogen octenyl succinate, an amphiphilic carbohydrate nanoparticle, and epsilon-polylysine to improve lipid oxidative stability of emulsions.
Siqi L Scheffler (2010)
10.1007/s00253-012-4439-8
The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections
Emma Myhrman (2012)
10.1016/S0966-842X(00)88982-9
The varied lifestyles of intracellular pathogens within eukaryotic vacuolar compartments.
F. García-del Portillo (1995)
10.1517/13543784.15.8.933
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment
Jamie S. Mader (2006)
10.1093/jac/dks212
Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model.
L. Sande (2012)
10.1016/j.ijpharm.2013.06.047
Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
C. Park (2013)
10.1016/j.ijantimicag.2013.07.009
Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model.
J. He (2013)
10.1152/PHYSREV.00034.2006
The physiology of glucagon-like peptide 1.
J. Holst (2007)
Nanocarriers for antibiotics
G. Yordanov (2014)
10.1186/cc5965
Acute kidney injury in the intensive care unit: current trends in incidence and outcome
D. Cruz (2007)
10.1073/PNAS.89.24.11939
Resistance to host antimicrobial peptides is necessary for Salmonella virulence.
E. Groisman (1992)
10.4315/0362-028X-67.5.922
Encapsulation of nisin and lysozyme in liposomes enhances efficacy against Listeria monocytogenes.
L. Were (2004)
10.1128/AAC.46.7.2200-2207.2002
Resistance to Quinupristin-Dalfopristin Due to Mutation of L22 Ribosomal Protein in Staphylococcus aureus
B. Malbruny (2002)
10.1016/j.chemphyslip.2011.09.004
Membrane-active host defense peptides – Challenges and perspectives for the development of novel anticancer drugs
Sabrina Riedl (2011)
10.1038/84627
Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator
D. Islam (2001)
10.1111/j.1574-6968.2010.02051.x
Generation of ramoplanin-resistant Staphylococcus aureus.
J. Schmidt (2010)
10.2147/IJN.S65289
Novel gramicidin formulations in cationic lipid as broad-spectrum microbicidal agents
Danielle Amt Ragioto (2014)
10.3390/ph7010058
Host-Defense Peptides with Therapeutic Potential from Skin Secretions of Frogs from the Family Pipidae
J. Conlon (2014)
10.1016/S0734-9750(03)00077-6
Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications.
M. Papagianni (2003)
10.4155/fmc.13.86
Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria.
Nina Bionda (2013)
10.1007/BF01569822
Dental plaque as a biofilm
P. D. Marsh (2005)
10.1208/pt0801026
Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system
J. Faraj (2008)
10.7150/ijms.6276
Effect of Hemoperfusion Using Polymyxin B-immobilized Fibers on Acute Lung Injury in a Rat Sepsis Model
T. Iba (2014)
10.1007/s00253-011-3135-4
Wound dressings for a proteolytic-rich environment
Andreia Vasconcelos (2011)
10.1038/nrd2153
Inhaling medicines: delivering drugs to the body through the lungs
John S. Patton (2007)



This paper is referenced by
10.1007/s11274-020-02907-1
Antimicrobial peptide polymers: no escape to ESKAPE pathogens—a review
Songhita Mukhopadhyay (2020)
10.1016/j.bmcl.2017.03.003
Elucidation of structural and functional integration of a novel antimicrobial peptide from Antheraea mylitta.
Suhrid R. Dutta (2017)
10.2217/nnm-2018-0337
A comparison of different strategies for antimicrobial peptides incorporation onto/into lipid nanocapsules.
N. Matougui (2019)
10.3390/molecules23030630
In Vitro ADME Properties of Two Novel Antimicrobial Peptoid-Based Compounds as Potential Agents against Canine Pyoderma
Ines Greco (2018)
10.1007/978-3-030-01881-8_1
Advances in Drug Delivery Strategies for Microbial Healthcare Products
J. M. Ageitos (2019)
Identification et caractérisations physico-chimiques et pharmacologiques de nouvelles molécules bioactives isolées à partir de venins d’animaux : exemple des peptides antimicrobiens
Chloé Mollet (2017)
10.3390/ijerph15071408
Self-Assembled Antimicrobial Nanomaterials
A. M. Carmona-Ribeiro (2018)
10.1080/13102818.2019.1611385
Antimicrobial activity, mechanism of action, and methods for stabilisation of defensins as new therapeutic agents
M. Amerikova (2019)
10.1038/s41598-017-04670-0
Nano-engineering the Antimicrobial Spectrum of Lantibiotics: Activity of Nisin against Gram Negative Bacteria
M. Vukomanović (2017)
10.3390/ijms17091578
Recent Advances in Antimicrobial Polymers: A Mini-Review
K. Huang (2016)
10.1159/000491497
Design and Assessment of Anti-Biofilm Peptides: Steps Toward Clinical Application
Melanie Dostert (2018)
10.1039/c9ra10135g
Nisin/polyanion layer-by-layer films exhibiting different mechanisms in antimicrobial efficacy
Hanan Fael (2020)
10.3389/fcimb.2019.00128
Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics—A Novel Way to Combat Antibiotic Resistance?
M. Zharkova (2019)
10.3390/molecules24050892
The Concept of an Ideal Antibiotic: Implications for Drug Design
M. Gajdács (2019)
10.5772/68020
The Versatile Dioctadecyldimethylammonium Bromide
A. M. Carmona-Ribeiro (2017)
10.1007/978-1-4939-6737-7_5
High-Performance Liquid Chromatography and Mass Spectrometry-Based Design of Proteolytically Stable Antimicrobial Peptides.
M. Bagheri (2017)
10.1039/c7sm02152f
Antimicrobial action of the cationic peptide, chrysophsin-3: a coarse-grained molecular dynamics study.
Andrea Catte (2018)
10.1007/s12602-019-9526-z
The Galactose-Binding Lectin Isolated from Vatairea macrocarpa Seeds Enhances the Effect of Antibiotics Against Staphylococcus aureus–Resistant Strain
V. F. Santos (2019)
10.1016/j.cbi.2015.08.023
Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells.
Yu-Li Lo (2015)
Nanostructures and nanomaterials for antimicrobial peptides (AMPs) delivery
M. C. Teixeira (2016)
10.1371/journal.pone.0214411
Antimicrobial biopolymer formation from sodium alginate and algae extract using aminoglycosides
L. Kumar (2019)
10.1007/s00726-016-2328-7
Molecular imaging of fibrosis using a novel collagen-binding peptide labelled with 99mTc on SPECT/CT
L. Zheng (2016)
10.1016/j.actbio.2016.11.026
Potential applications of antimicrobial peptides and their mimics in combating caries and pulpal infections.
Sui Mai (2017)
10.1007/978-3-319-32949-9_10
How to Teach Old Antibiotics New Tricks
Stephanie Deshayes (2016)
10.1016/j.genrep.2020.100811
Oral antimicrobial peptides and new therapeutic strategies for plaque-mediated diseases
N. Izadi (2020)
10.3390/ph13050083
Polymyxin Delivery Systems: Recent Advances and Challenges
N. Dubashynskaya (2020)
10.1016/j.jcis.2018.07.125
Antimicrobial peptide encapsulation and sustained release from polymer network particles prepared in supercritical carbon dioxide.
Rahmet Parilti (2018)
10.1016/j.foodchem.2016.06.075
Encapsulation of bioactive whey peptides in soy lecithin-derived nanoliposomes: Influence of peptide molecular weight.
A. Mohan (2016)
10.4018/978-1-5225-0754-3.CH001
Personalized Approach in Nanomedicine: Understanding Adverse Effects and Their Risk Assessment
M. Vlasova (2017)
10.1007/s12602-017-9330-6
Bacteriocinogenic LAB Strains for Fermented Meat Preservation: Perspectives, Challenges, and Limitations
L. Favaro (2017)
10.3390/ijms16036337
Supramolecular Cationic Assemblies against Multidrug-Resistant Microorganisms: Activity and Mechanism of Action
Letícia Dias de Melo Carrasco (2015)
10.1111/jfpp.14369
Antimicrobial peptides from the edible insect Musca domestica and their preservation effect on chilled pork
X. Dang (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar